Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.40 |
| ▸ | NLRP3 | Q96P20 | 8/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8513390 | 0.73 | PTGS2 (0.48) | PTGS2NLRP3CYP2D6CYP2C9CYP2C19 | |
| Carabrone SCHEMBL30046035 | 0.71 | NLRP3 (0.40) | PTGS2NLRP3CYP2D6CYP2C9CYP2C19 | |
| Tomentosin SCHEMBL10028477 | 0.58 | KDR (0.58) | PTGS2NLRP3 | |
| SCHEMBL31379748 | 0.58 | KDM1A (0.49) | PTGS2NLRP3CYP2D6CYP2C9CYP2C19 | |
| Alloalantolactone SCHEMBL29934802 | 0.58 | NLRP3 (0.50) | PTGS2NLRP3CYP2D6CYP2C9CYP2C19 | |
| Alloalantolactone SCHEMBL30105635 | 0.58 | NLRP3 (0.50) | PTGS2NLRP3CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL31079521 | 0.58 | POLB (0.74) | — | |
| SCHEMBL31079567 | 0.58 | POLB (0.74) | — | |
| SCHEMBL30954259 | 0.58 | POLB (0.74) | — | |
| Carabrol SCHEMBL30932148 | 0.57 | PTGS2 (0.39) | PTGS2NLRP3CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210346385-A1 | TASTE-MASKED DOSAGE FORMS | DEEP OCEAN CAPITAL MANAGEMENT LP | 2021-11-11 | — | — | US | disclosed |
| WO-2020061584-A1 | TASTE-MASKED DOSAGE FORMS | MSB HOLDINGS, INC. (US) | 2020-03-26 | — | — | WO | disclosed |